Dialectical Behavior Therapy vs Enhanced Usual Care for Suicidal and Self-harming Adolescents. 10 Year Follow-up
Launched by OSLO UNIVERSITY HOSPITAL · Mar 4, 2020
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
Suicide attempts and non-suicidal self-harm, highly prevalent in adolescents, are behaviours strongly associated with severe emotion dysregulation, mental health problems and increased suicide risk. The original study, on which the present study is building, used a randomized controlled design, with a stratified block randomization procedure, and blinded pre-treatment, post-treatment and follow-up evaluations comparing 19weeks of DBT-A with EUC of equal length.
Of special interest to this follow-up study is to gain more knowledge on their capacity to regulate emotions, since failures in em...
Gender
ALL
Eligibility criteria
- The inclusion criteria for the initial study were:
- • 1. History of repeated self-harm (last episode within last 4 months) and
- • 2. Age between 12 and 18 years and
- • 3. Satisfied at least 2 criteria of DSM-IV Borderline Personality Disorder (BPD) (as measured by the SCIDII) (in addition to the self-destructive criterion) - alternatively at least 1 criterion of DSM-IV BPD plus at least 2 threshold level criteria and
- • 4. Written informed consent from patient and parent(s) to participate in the study and
- • 5. Patient fluently Norwegian speaking
- Exclusion Criteria:
- • 1. Psychotic disorders or
- • 2. Anorexia nervosa or
- • 3. Severe substance dependence disorders or
- • 4. Mental retardation (IQ less than 70) or
- • 5. Asperger syndrome/autism -
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Lars Mehlum, MD PhD
Principal Investigator
University of Oslo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials